"Should I Try Ozempic?" Why I Ask You Four Questions First
Nov 1, 2026
It is one of the most common questions we hear. If a friend asked me, my answer would start with more questions:
Why do you want to try Ozempic? Are you dieting and exercising? Have you been trying to lose weight? Have you seen your primary care doctor to rule out diabetes, and conditions like hypothyroidism that can cause weight gain, or lack of weight loss?
Dr. Vanitha Yadalla
That is not me saying no. These medicines can be a real turning point. It is me making sure that if you start one, it actually works for you, and keeps working.
First, what these medicines can do
The results are real. In the major studies, people lost about 15 percent of their body weight on the standard Wegovy dose and up to about 21 percent on Zepbound1,2. In adults with heart disease and extra weight, Wegovy lowered the risk of heart attack, stroke, or heart-related death by 20 percent3.
Share of body weight. STEP 1 (2021) and SURMOUNT-1 (2022) trials.
One thing that confuses a lot of people: Ozempic and Wegovy are the same medicine (semaglutide). Ozempic is the version approved for type 2 diabetes. Wegovy is the version approved for weight4. So when a friend says "I'm on Ozempic for weight," the weight version is actually Wegovy.
Where lifestyle fits in the bigger picture
Here is the part the ads leave out. The medicine changes your appetite. It does not change your habits on its own.
The American College of Physicians, the national group for internal medicine doctors, now recommends these medicines as first choices when medicine is right for you, but always alongside changes in eating and activity5,6. Even Medicare's new $50 a month coverage asks your doctor to confirm you are in a diet-and-exercise program7.
In our view, medicine works best for people who have already given eating and exercise a real try. GLP-1 medicines are not a quick fix. We coach you on food and movement first, and if you have truly tried and the weight is not coming off, we start the medicine alongside those changes.
Why this matters even more after 55
You can lose muscle along with fat. In a body-scan study from the main Wegovy trial, about 38 percent of the weight people lost was lean mass, which includes muscle1,8. After 55, muscle is hard to win back, and it is what keeps you steady on your feet.
What I wish every patient knew:
This could be a long-term drug. You lose muscle as well as fat, so you may feel weaker if you do not strength train.
Dr. Vanitha Yadalla
The good news is that habits change what you lose. In one study of adults around age 70, everyone lost about 19 pounds through diet and exercise. The groups that did strength training lost the least muscle (about 2 to 4 pounds, compared with 6 pounds in the walking and cycling group), and got 18 to 19 percent stronger9. That was a diet study, not a GLP-1 study, but the lesson carries over.
Everyone lost about 19 lb. A diet study, not a GLP-1 study (Villareal, 2017). Less is better.
The weight tends to come back if you stop. One year after stopping, people in a major trial had regained about two-thirds of the weight they lost10. A 2026 review of 37 studies found weight came back about four times as fast after stopping weight-loss medicines as after ending a diet-and-exercise program11. The habits you build are what hold your results.
STEP 1 extension trial, 2022.
What I worry about
I worry this is the easy way, the easy fix. I worry they don't realize how long it takes.
Dr. Vanitha Yadalla
National nutrition and obesity groups have said it plainly: "many individuals prescribed GLP-1s have not received meaningful nutrition or other lifestyle guidance"8. That is the gap we try to close.
What "lifestyle first" looks like in real life
It is not "go away and come back when you have lost 20 pounds." It looks like this:

- A real look at the whole picture. Labs, thyroid, blood sugar, sleep, and the medicines you already take.
- Protein at every meal. Many adults need roughly 80 to 120 grams a day during weight loss8.
- Strength training at least three times a week8.
- Help with food from a dietitian, so you are eating enough of the right things.
- Then, if you have truly tried and the weight is not moving, the medicine, at the lowest dose that works, with those habits already in place.

And the other way it can go, the way I love to see: a patient uses the medicine for a few months, learns how to eat, starts exercising, and then keeps going with the lifestyle changes on their own.
When to talk to your doctor
If you are thinking about a GLP-1, bring these questions to your next visit:
- Have we ruled out thyroid problems, diabetes, or medicines that cause weight gain?
- What would a real lifestyle plan look like for me, and who will help me with it?
- If I start a medicine, how will we protect my muscle?
- What is our plan if I want to lower the dose or stop someday?
The bottom line
GLP-1 medicines are powerful tools. Used as one part of a whole-person plan, they can change your health. Used as a shortcut, they often disappoint. You deserve the version that lasts.
If you would like to talk it through with me, start here: www.yhealth.com/newpatient
This article is for general education and is not medical advice. Talk with your own doctor about what is right for you.
Sources (11)
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). <i>N Engl J Med</i>. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). <i>N Engl J Med</i>. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). <i>N Engl J Med</i>. 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563
- Wegovy (semaglutide) injection and tablets, Full Prescribing Information. Novo Nordisk; revised June 2026. DailyMed.
- Qaseem A, et al. Pharmacologic treatments with lifestyle modifications in nonpregnant adults with overweight or obesity in outpatient settings: a living clinical guideline from the American College of Physicians (April 2026). <i>Ann Intern Med</i>. Published online June 2026. doi:10.7326/ANNALS-25-02714
- American College of Physicians. ACP issues new living clinical guideline on using medications to manage overweight and obesity [press release]. June 15, 2026.
- Medicare.gov, Weight loss drugs: Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027); CMS Innovation Center, BALANCE Model.
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Co-published 2025 in <i>Am J Lifestyle Med</i>, <i>Am J Clin Nutr</i>, <i>Obesity</i>, and <i>Obesity Pillars</i>.
- Villareal DT, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. <i>N Engl J Med</i>. 2017;376(20):1943-1955.
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. <i>Diabetes Obes Metab</i>. 2022;24(8):1553-1564. doi:10.1111/dom.14725
- West S, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. <i>BMJ</i>. 2026;392:e085304. doi:10.1136/bmj-2025-085304
Thinking about a GLP-1? Start with our New Patient guide.
